U.S. Banks Stock News

Why Tango Therapeutics Is On Investors’ Radar Tango Therapeutics (TNGX) has drawn attention after a very large 1 year total return of 10.16%, alongside sizeable moves over the past month and past 3 months. For a precision oncology company still reporting a net loss of US$101.594 million on revenue of US$62.384 million, that kind of share price performance naturally raises questions about how investors are weighing its current fundamentals. See our latest analysis for Tango Therapeutics. The...

Context for Ashland after recent share price moves Ashland (ASH) has come back into focus for investors after a period of weaker share performance, with the stock showing declines over the past month, past 3 months, year to date, and over the past year. See our latest analysis for Ashland. At a share price of $48.81, Ashland’s recent 1 month share price return of 24.68% and 3 year total shareholder return of 47.02% point to pressure on sentiment rather than building momentum. If Ashland’s...

Adobe agreed to acquire Semrush for about $1.9b, aiming to add AI powered performance marketing and search capabilities to its product stack. The company is rolling out autonomous AI agents internally to support operations, with reported efficiency gains across key workflows. These moves come alongside an active CEO transition process that could reshape leadership priorities at Adobe. Adobe, NasdaqGS:ADBE, is making these moves while its share price stands at $248.15, with a value score of...

Earlier in March 2026, Diamondback Energy completed a follow-on equity offering of 11,000,000 common shares at US$173 each, raising about US$1.90 billion at a per-share discount of US$2.81. This sizable capital raise, which increases the company’s share count, could influence how investors assess its future capital allocation and production plans. Next, we’ll examine how this sizeable equity raise may reshape Diamondback Energy’s investment narrative centered on consolidation, efficiency and...

StepStone Group (STEP) has put two clear signals in front of investors: a new share repurchase program of up to US$100 million and a broad round of senior promotions across its global platform. See our latest analysis for StepStone Group. Those moves come as the share price sits at US$46.73, with a 7 day share price return of 4.1% but a 90 day share price return decline of 29.7%, alongside a 3 year total shareholder return of about 2.1x and a 1 year total shareholder return decline of 15.1%,...

Hilton Grand Vacations (HGV) recently opened Tradimo Kyoto Gojo in Japan, adding 63 one bedroom suites and expanding its resort footprint in Kyoto, while emphasizing sustainable tourism and local community partnerships. See our latest analysis for Hilton Grand Vacations. Despite the Kyoto opening and recent board changes, HGV’s share price has faced a 17.1% decline over the past 30 days and an 11.54% year to date share price return, while the 1 year total shareholder return is 2.94%. This...

Middle East tensions put Golar LNG (GLNG) in focus A missile attack on a major Qatari natural gas hub, a key supplier of global LNG, has pushed investors toward LNG exposed names such as Golar LNG (GLNG), amid concerns around potential supply disruptions. See our latest analysis for Golar LNG. The news-driven spike in LNG prices has been reflected in Golar LNG’s share price, with a 1-day share price return of 3.36%, a 7-day return of 17.41%, and a 90-day return of 41.36%. Total shareholder...

In March 2026, Locus Cell Co., Ltd. announced it had signed a Memorandum of Understanding with Charles River Laboratories to explore collaboration on CMC support, analytical testing, technical development, and related services for advanced therapy developers across Taiwan and the wider Asia-Pacific region. This agreement links Charles River’s global biologics testing expertise with Locus Cell’s cell and gene therapy manufacturing platforms, highlighting a potential build-out of integrated...

Relay Therapeutics recently reported updated Phase 1/2 ReDiscover trial data showing that zovegalisib (RLY-2608) plus fulvestrant at a 400mg twice-daily fed dose delivered efficacy and tolerability in PI3Ka-mutated, HR+/HER2- metastatic breast cancer consistent with its earlier 600mg fasted regimen, and confirmed this as the recommended Phase 3 dose. The data, presented at ESMO TAT 2026, underpin the ongoing global Phase 3 ReDiscover-2 trial and build on the regimen’s FDA Breakthrough...

Uber Technologies (NYSE:UBER) is rolling out a hybrid network that blends human drivers with autonomous robotaxis across select markets. Early operating data from these deployments indicates higher vehicle utilization and quicker pickup times when riders can choose between both options. The company is using these results to refine how it allocates trips between human drivers and autonomous partners on its platform. For investors watching NYSE:UBER, this hybrid approach ties directly to its...

Recent performance snapshot Benchmark Electronics (BHE) has attracted fresh attention after recent share moves, with the stock showing a 3.6% decline over the past day and about a 7.5% decline over the past month. See our latest analysis for Benchmark Electronics. While the recent 7.5% 30 day share price decline may feel uncomfortable, Benchmark Electronics still shows stronger momentum over longer periods, with a 90 day share price return of 20.9% and a 1 year total shareholder return of...

Some investors may be wondering whether Walmart's current share price still offers value after a strong run, or whether most of the potential upside is already reflected in the stock. Over the past year, the stock returned 37.2%, with year to date returns of 5.6% and shorter term moves of 3.2% over 30 days and 5.5% over 7 days. These moves may signal shifting views on risk and reward. Recent headlines have focused on Walmart's ongoing push into e commerce and membership offerings, as well as...

On 10 March 2026, the Human Animal Bond Research Institute announced a new partnership with Trupanion to align pet insurance with scientific research on the human–animal bond, including support for veterans and service dogs. This collaboration links Trupanion with evidence-based advocacy on how pets benefit physical and mental health, potentially strengthening its brand with veterinarians, pet owners, and mission-driven partners. We’ll now examine how Trupanion’s alignment with human–animal...

Earlier in March 2026, SM Energy Company issued US$1,000,000,000 of 6.625% Senior Notes due 2034 and launched an expanded cash tender offer of up to US$1,000,000,000 for its inherited 8.375% Senior Notes due 2028, with about 58.04% of the outstanding principal already tendered. This refinancing push highlights how SM Energy is actively reshaping its post‑Civitas debt stack, potentially lowering interest costs and extending its maturity profile. Next, we’ll examine how this large-scale debt...

In March 2026, United Natural Foods, Inc. reported second-quarter net income of US$20 million on sales of US$7.95 billion, raised full-year earnings guidance while trimming its sales outlook, completed a US$87.73 million share repurchase program, and advanced a major supply chain overhaul including a distribution center closure and job cuts. This combination of improved profitability, capital returns, and a shift toward automation and AI-enabled logistics marks a significant reshaping of how...

Recent share performance puts Global Payments in focus Global Payments (GPN) has drawn attention after a one-month return of about a 17% decline and a three-month return of roughly a 15% decline, prompting investors to reassess expectations around the payment technology group. See our latest analysis for Global Payments. The recent 1-month share price return of a 16.9% decline and 1-year total shareholder return of a 30.0% loss point to fading momentum, even with small gains over the past...

Event context and recent share performance Alliant Energy (LNT) shares recently pulled back around 3.7% in a day and about 5.9% over the past week, bringing the stock to a last close of $68.71 for investors tracking short term moves. See our latest analysis for Alliant Energy. Zooming out, the recent share price pullback sits against a steadier backdrop, with a 90 day share price return of 5.29% and a 1 year total shareholder return of 12.61%. This suggests momentum has eased, but longer term...

What recent price moves suggest about Nelnet Nelnet (NNI) has seen its share price ease, with a 0.8% decline over the past day and softer performance over the week, month, and past 3 months, putting recent returns in focus for investors. See our latest analysis for Nelnet. While the recent share price return over the past quarter has been weaker, the 1 year total shareholder return of 12.33% and 5 year total shareholder return of 82.47% point to a much stronger longer term picture. If you are...

Why Global Ship Lease Stock Is On Investors’ Radar Global Ship Lease (GSL) has drawn fresh interest after recent share price moves, with the stock down about 6% over the past month but up around 10% in the past 3 months. See our latest analysis for Global Ship Lease. Recent trading has been choppy, with a 1 day share price return of 2.38% decline and a 30 day share price return of 6.11% decline. However, the 1 year total shareholder return of 72.68% and 5 year total shareholder return of...

Medical Properties Trust (MPT) has drawn investor attention after recent trading, with the share price at $4.56 and total return figures showing declines over the past month and past 3 months. See our latest analysis for Medical Properties Trust. The recent 1 month share price return of 19.43% decline and 1 year total shareholder return of 19.91% decline indicate fading momentum, with short term weakness sitting on top of already pressured longer term performance. If this has you thinking...

Teekay Corporation Ltd. has reported past full-year 2025 results, with sales of US$949.52 million and net income of US$98.11 million, both lower than the prior year. The decline in basic earnings per share from continuing operations, from US$1.47 to US$1.14, underscores pressure on Teekay’s underlying profitability. With earnings showing reduced revenue and profit, we’ll examine how this softer performance shapes Teekay’s investment narrative going forward. The latest GPUs need a type of...

Dynex Capital (DX) has moved into focus after its board declared a cash dividend of $0.17 per common share for March 2026, along with a quarterly Series C preferred dividend of $0.58711 per share. See our latest analysis for Dynex Capital. The dividend news comes as Dynex Capital’s share price has softened, with a 1 day share price return showing a 4.47% decline, a 30 day share price return showing a 12.31% decline, yet a 3 year total shareholder return of 57.99% indicates longer term holders...

Apogee Therapeutics recently reported positive 52-week maintenance data from Part A of its Phase 2 APEX trial of zumilokibart in moderate-to-severe atopic dermatitis, showing durable responses and a safety profile generally in line with other drugs in the class. The data highlight the potential for meaningfully less frequent dosing than many existing treatments, while still delivering deepening improvements in skin lesions and itch over a full year. Next, we’ll examine how the prospect of...

Wondering if Sonos at around US$13.12 is a bargain or just fairly priced for the risks involved? This article unpacks what the current share price actually reflects. The stock has had a mixed return profile, with a 9.2% gain over the last year, a 25.0% decline year to date, and a 64.2% decline over five years. This can change how the market views its potential and risk. Recent news flow around Sonos has focused on its position in the consumer durables space and how investors are reassessing...